Status:
UNKNOWN
Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Lead Sponsor:
Asan Medical Center
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
In suspecting pancreatic cancer, dynamic phase pancreatic CT is the most effective tool in diagnosis and staging. In addition, magnetic resolution image, endoscopic ultrasonography, endoscopic retrogr...
Detailed Description
Compared to dynamic phase pancreatic CT, integrated PET-CT will be evaluated for sensitivity, specificity and accuracy of diagnosing and staging pancreatic cancer while the gold standard for pancratic...
Eligibility Criteria
Inclusion
- Pancreatic mass suspicious of pancreatic cancer
- No comorbidity, expected life expectancy less than 6 months
- Consent this study in letter
Exclusion
- Refuse diagnostic and staging work-up
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00885248
Start Date
January 1 2009
End Date
December 1 2009
Last Update
April 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736